As you know, I am reviewing chapter by chapter G. Edward Griffin’s book “World Without Cancer. It’s a book about Laetrile also known, commonly, as Vitamin B17. So far it has been a fairly good read. Chapter 1 was a bit dry and mostly discussed clinical studies, the politics of the medical industry and some of the corruption that seems to have tainted the honest evaluation of the substance called Laetrile. It was worth reading because it highlighted a number of cases that were “eye openers”. It’s really just a warm up for chapter 2.
Chapter 2 is nowhere near as dry as chapter one. It hits the ground running and you can tell just from comparing the chapter titles. The main focus of the second chapter is the constant battle of doctors, scientists and medical professionals trying to get an honest evaluation of Laetrile accepted and approved for use in the fight against cancer. The chapter is very technical but not dry at all. In fact, it is a fast moving chapter and could almost be a modern medical thriller if it was a movie. Erin Brockovich couldn’t have written it better.
G. Edward Griffin explains in Chapter 2 that there are really 2 different paradigms at work in the cancer industry. One is the standard view which is includes surgery, chemo, radiation and you know the rest. The other is laid out in chapter 2 and is explained fairly well in the quote below:
How does one evaluate the success of a cancer treatment? Is it the length of Life? The quality of life? The feeling of well-being and absence of pain? They are not concerned with the size of a tumor because, as stated previously, they know most tumors are a mixture of malignant and benign cells and that most have only a small percentage of cancer cells. If Laetrile removes 100% of a patient’s cancer, his tumor may only decrease by 10% or 15%. But who cares? The patient is back among the living again. The tumor is not the disease; it is merely the symptom of the disease.
Orthodox medicine, on the other hand, is totally focused on the tumor. To most oncologists, the tumor is the cancer. If they remove it surgically or burn it away, they happily announce to the patient: “Good news. We got it all!” They may have all of the tumor, but did they get what caused the tumor? And, in the process, did they dislodge some of those malignant cells, causing them to migrate throughout he circulatory system only to find new homes elsewhere in the body? Is that the reason so may cancer patients die of metastasized cancer to multiple locations only a few months after hearing those ludicrous words: “We go it all”?
Laetrile practitioners believe that reduction in tumor size is the least meaningful of all the measures of success.
G. Edward Griffin goes on to show how a number of doctors had completed numerous studies and issued summaries and reports in favor of using Laetrile in the fight against cancer. He also documents very well how standard medical practitioners resisted and even obfuscated the results. For example, there is the now famous Dr. Kanematsu Sugiura who, while working at Sloan Kettering Memorial Hospital, published a Summary of the effect of Amygdalin Upon Spontaneous Mammary Tumors in Mice (Sloan-Kettering report, June 13, 1973). What did the summary say about Dr. Sugiura? Here’s another quote for you.
The results clearly show that Amygdalin significantly inhibits the appearance of lung metastasis in mice bearing spontaneous mammary tumors and increases significantly the inhibition of the growth of the primary tumors…. Laetrile also seemed to prevent slightly the appearance of new tumors…. The improvement of health and appearance of the treated animals in comparison to controls is always a common observation… Dr. Sugiura has never observed complete regression of these tumors in all his cosmic experience with other chemotherapeutic agents.
Yet in a study conducted by Dr. Sugiura, and launched by the National Cancer Institute, 2 patients showed complete response (total tumor disappearance), 4 had partial regression (greater than 50%), 9 were “stabilized” (tumors had stopped growing), and 3 had “increased disease-free intervals. 82% benefited from B17.
Who was Dr. Sugiura? Let me give you a quick profile. Dr. Sugiura conducted meticulous studies regarding Laetrile for 5 years at Sloan Kettering. He was the senior laboratory researcher there with over 60 years of experience. He had earned the highest respect for his knowledge and integrity. Here’s a quote regarding Dr. Sugiura.
Few, if any, names in cancer research are as widely known as Kanematsu Sugiura’s….Possibly the high regard in which his work is held is best characterized by a comment made to me by a visiting investigator in cancer research from Russia. He said, “When Dr. Sugiura publishes, we know we don’t hve to repeat the study for we would obtain the same results he has reported.” Mr. Griffin was again quoting The Cancer Syndrome by Ralph Moss.
Big Pharma At Work?
Mr. Griffin continues his revealing chapter with a grouping of facts that when put together make his case fairly well. The board of directors at Sloan-Kettring, at the time, was almost completely controlled by corporate executives representing the financial interests of the pharmaceutical companies. Most of the control was held by the Rockefellers and those in league with them. The Morgans were also on the board…..as in J.P. Why does this matter? The Rockefellers began donating to Sloan-Kettering back in 1927, they later donated the land that the hospital was built on and so, they and their allies were given control over the board. Wall Street was in control of the board and stood to gain or lose large sums of money depending on how the cancer war was executed. You can read more if you pick up “The Cancer Syndrome” by Ralph Moss. The problem with this arrangement should be obvious since they were on the board as corporate heads and not doctors. By definition they were looking for profits and not necessarily anything else.
To assume that the hospital was being run for the main purpose of profit without any proof, or at least circumstantial evidence, would seem paranoid. That is why chapter 2 is so good in this book. Mr. Griffin lays out quite a damning case against some of the household names in the cancer “industry”. Let’s look at some more examples.
As it turns out, Dr. Sugiura’s experiments were duplicated and verified by other doctors such as Dr. Elizabeth Stockert and Dr. Lloyd Schloen. They were both biochemists at Sloan-Kettering at the time of their studies. Dr Schloen reported a 100% cure for Swiss Albino Mice by adding proteolytic enzymes to the injections. According to Mr. Griffin, new studies were done with the sole purpose of discrediting these results and to muddy the waters. A number of these “new” studies were discredited later. They were discredited after important decisions had been made, papers had been signed and the tide had been turned against Laetrile. Later Sloan-Kettering stated that Dr. Sugiura’s work had never been duplicated which as you can see is not true. You can read more details when you read the book.
Mr. Griffin is not the only one to feel that this was an unfair characterization of Laetrile and Dr. Sugiura’s work. A publication called the “Second Opinion” was started and was formed by a group of Sloan-Kettering employees. It was series of open letters to the public designed to inform the public of the “cover up” going on regarding the work with Laetrile. The employees were anonymous for the most part but because of the detailed medical records, data and internal Sloan-Kettering memos published by them it became obvious that they were highly connected. As the battle wore on, even Dr. Sugiura voiced his anger regarding how he and his studies were being maligned. Later, through the freedom of information act, it came out that a number of doctors at Sloan-Kettering were convinced that Laetrile was effective.
Chapter 2 concludes with a note pointing out that regardless of the FDA, opposition from “Big Pharma” or the NCI (National Cancer Institute) thousands and thousands of people are now taking Laetrile and some hospitals are even now starting to use it in the “protocols” to fight certain cancers. It seems that some light is being shed on the subject at last.
I will keep you posted as I read more,